[Trial of a long-acting preparation Coldact from the firm NATKO to treat upper respiratory tract diseases in polyclinics].
Rumiantsev
A G
AG
Aldonina
V V
VV
Il'ina
T P
TP
Snitsarenko
V I
VI
Biriuchinskaia
I G
IG
Shevaldina
T V
TV
D000284:Administration, Oral; D000328:Adult; D000553:Ambulatory Care; D002214:Capsules; D002648:Child; D002744:Chlorpheniramine / Q000627:therapeutic use*; D003692:Delayed-Action Preparations; D004338:Drug Combinations; D006801:Humans; D010665:Phenylpropanolamine / Q000627:therapeutic use*; D012140:Respiratory Tract Diseases / Q000188:drug therapy*; D012996:Solutions
D002214:Capsules; D003692:Delayed-Action Preparations; D004338:Drug Combinations; D012996:Solutions; C083542:chlorpheniramine, phenylpropanolamine drug combination; D010665:Phenylpropanolamine; D002744:Chlorpheniramine
Opyt primeneniia v poliklinicheskikh usloviiakh Koldakta--preparata prolongirovannogo deĭstviia firmy NATKO dlia lecheniia zabolevaniĭ verkhnikh dykhatel'nykh puteĭ.